• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB1100442 注射用重组人白介素-2(125Ala) Recombinant Human Interleukin-2(125Ala) Lyophilized Biological Products Supplementary Application 2012-07-06 哈高科白天鹅药业集团有限公司 Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd Certificate Issued 2014-07-24 view
CYSB1100444 注射用重组人白介素-2(125Ala) Recombinant Human Interleukin-2(125Ala) Lyophilized Biological Products Supplementary Application 2012-07-06 哈高科白天鹅药业集团有限公司 Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd Certificate Issued 2014-07-24 view
CYSB1100443 注射用重组人白介素-2(125Ala) Recombinant Human Interleukin-2(125Ala) Lyophilized Biological Products Supplementary Application 2012-07-06 哈高科白天鹅药业集团有限公司 Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd Certificate Issued 2014-07-24 view
CXSS0600058 注射用重组人白介素-2(125Ala) Recombinant Human Interleukin-2(125Ala) Lyophilized Biological Products(1) New Drug Application 2006-06-02 上海华新生物高技术有限公司 Shanghai Huaxin High Biotechnology Inc Certificate Issued 2008-09-01 view
CXSB0500075 注射用重组人白介素-2(125Ala) Recombinant Human Interleukin-2(125Ala) Lyophilized Biological Products Supplementary Application 2005-12-02 北京双鹭药业股份有限公司 Beijing SL Pharmaceutical Co Ltd Certificate Issued 2006-07-12 view